DIAGNOS and ÉTS Announce $1M Federal Investment for Retinal AI Innovation

BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Artificial Intelligence (AI), and the École de technologie supérieure (ÉTS) today announced a major federal investment exceeding 1 Million $CAD to accelerate the development of next-generation artificial intelligence for retinal image analysis.

DIAGNOS, a Canadian leader in artificial intelligence and retinal imaging, announced a significant federal investment of $1 million aimed at supporting its next-generation retinal AI innovations. This funding aligns with the strategic partnership formed with École de technologie supérieure (ÉTS), which is recognized for its expertise in technology and engineering education.

The investment from the federal government will boost DIAGNOS's capabilities in the development of advanced AI solutions that enhance the detection and management of retinal diseases. With the growing prevalence of retinal conditions globally, the need for innovative diagnostic tools has never been more critical. This partnership seeks to leverage cutting-edge technology that will improve patient outcomes through earlier diagnosis and intervention.

DIAGNOS is committed to employing its proprietary software, which integrates artificial intelligence into the process of analyzing retinal images. This technology has the potential to revolutionize how eye diseases are diagnosed, making it faster and more efficient. The collaboration with ÉTS will also involve research initiatives that focus on further refining AI algorithms and enhancing the accuracy of retinal disease detection.

Moreover, this investment promises to create job opportunities and enhance skill development within the province, contributing positively to the local economy. DIAGNOS aims to foster a culture of innovation while developing a pipeline of skilled professionals who can navigate the intersection of technology and healthcare.

The partnership between DIAGNOS and ÉTS underscores a commitment to advancing healthcare technology. By harnessing the power of artificial intelligence and deep learning in the field of ophthalmology, this collaboration is set to transform retinal healthcare, paving the way for preventative measures and more personalized treatment strategies.

Overall, the $1 million investment marks an important step in the evolution of retinal diagnostics. It embodies the collaborative efforts of the public and private sectors to tackle pressing healthcare challenges through innovative technological solutions.